Zdrowie i gospodarka · 13/12/2023

FDA Announces Summary of Comments on Patient Experience Data Methodology

The FDA has released a summary of comments received in response to its May 2, 2023 notice on methodological challenges related to patient experience data, which will inform the planning of two public workshops and future priorities.